• AI
  • Molecular Imaging
  • CT
  • X-Ray
  • Ultrasound
  • MRI
  • Facility Management
  • Mammography

J.D. Power and Associates Commissioned for Inaugural Health Care Information Technology Study


KANSAS CITY, Mo., Feb. 10 /PRNewswire-FirstCall/ -- In this climate of intense corporate scrutiny, do trust and transparency matter in the health care information technology (HCIT) buying equation? J.D. Power and Associates, as commissioned by Cerner

KANSAS CITY, Mo., Feb. 10 /PRNewswire-FirstCall/ -- In this climate of intense corporate scrutiny, do trust and transparency matter in the health care information technology (HCIT) buying equation? J.D. Power and Associates, as commissioned by Cerner Corporation , has conducted a study among health care executives to better understand the importance of disclosing key corporate measures that demonstrate suppliers' capabilities and commitment to HCIT.

Study results will be revealed at a presentation Monday, February 10 at 2:00 p.m. Pacific Standard Time at the 2003 HIMSS conference in San Diego in Media room 14B of the San Diego Convention Center. Steven Wood, executive director for the health care division of J. D. Power and Associates and Neal Patterson, chairman and chief executive officer of Cerner Corporation will be explaining the significance of these important findings.

J.D. Power and Associates is the authoritative voice on client satisfaction. Each year, the firm conducts studies in more than 60 countries to better understand clients' opinions and expectations regarding the products and services they purchase. The firm's studies have become industry benchmarks for measuring quality and client satisfaction in many industries worldwide. This is the first HCIT study conducted by J.D. Power and Associates, and is critical in its timing because of the increasing acceptance of HCIT as a key strategy to address the major issues within health care today, and the growing need for a more full disclosure by HCIT suppliers.

J.D. Power and Associates has posed a set of questions to health care executives on the importance of full disclosure, and HCIT suppliers were surveyed on seven top criteria for trust. These criteria include:

-- Disclose annual revenues -- Disclose annual research and development on modern solutions -- Disclose rollout status of modern solutions -- Demonstrate solutions on live code -- Vouch for the veracity of all public statements -- Disclose human resource allocations -- Disclose conversions

"The American health care system is in crisis. Technology is a key solution," said Neal Patterson, chairman and chief executive officer for Cerner Corporation. "If we are to make an effective case to health care executives and national policy makers, our industry must hold itself to a higher standard."

Cerner Corporation is the leading supplier of clinical and management information and knowledge systems to more than 1,500 health care organizations worldwide. Cerner is working to transform the health care delivery system by increasing the quality of care, improving efficiencies, eliminating medical error and connecting the individual to the system with innovative information solutions. The following are trademarks of Cerner: Cerner, and Cerner's logo. Nasdaq: CERN, http://www.cerner.com/

Cerner Corporation

CONTACT: Media, Jessica Weeks, +1-816-201-5114, jweeks@cerner.com , or
Investors, Allan Kells, +1-816-201-2445, akells@cerner.com , both of Cerner

Web site: http://www.cerner.com/

Related Videos
Emerging Research at SNMMI Examines 18F-flotufolastat in Managing Primary and Recurrent Prostate Cancer
Could Pluvicto Have a Role in Taxane-Naïve mCRPC?: An Interview with Oliver Sartor, MD
New SNMMI President Cathy Cutler, PhD, Discusses Current Challenges and Goals for Nuclear Medicine
Where the USPSTF Breast Cancer Screening Recommendations Fall Short: An Interview with Stacy Smith-Foley, MD
A Closer Look at MRI-Guided Transurethral Ultrasound Ablation for Intermediate Risk Prostate Cancer
Improving the Quality of Breast MRI Acquisition and Processing
Can Fiber Optic RealShape (FORS) Technology Provide a Viable Alternative to X-Rays for Aortic Procedures?
Does Initial CCTA Provide the Best Assessment of Stable Chest Pain?
Making the Case for Intravascular Ultrasound Use in Peripheral Vascular Interventions
Can Diffusion Microstructural Imaging Provide Insights into Long Covid Beyond Conventional MRI?
Related Content
© 2024 MJH Life Sciences

All rights reserved.